Agency / Source: Health Decisions

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Health Decisions CEO Explores Adaptive Monitoring Techniques for Late-Stage Clinical Studies at DIA - Dr. Michael Rosenberg will describe how fast access to metrics, flexible processes, and automated technology enable study monitors to increase efficiency
Health Decisions CEO Explores Adaptive Monitoring Techniques for Late-Stage Clinical Studies at DIA

 

PRZOOM - /newswire/ - Durham, NC, United States, 2010/06/08 - Dr. Michael Rosenberg will describe how fast access to metrics, flexible processes, and automated technology enable study monitors to increase efficiency.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Health Decisions (Booth 929), a full-service clinical research organization (CRO) specializing in high-efficiency adaptive solutions, announces that CEO Michael Rosenberg, MD, MPH will join a panel June 14 at the DIA Annual Meeting in Washington, DC. "Centralized Monitoring: When Does It Make Sense?" will focus on the advantages and requirements of monitoring programs that balance the needs of sponsor companies and investigative sites in phase IIIb to postmarket clinical studies.

According to Dr. Rosenberg, a centralized monitoring system should be based on the same general principle as adaptive design, a hot topic in the industry. Adaptive monitoring involves capturing and presenting site performance metrics to study monitors in near-real time, allowing monitors to make mid-course adjustments to study operations based on current information. This enables decision-makers to optimize site activity on a rolling and continuous basis for dramatic aggregate time- and cost-savings.

“Applied to site management, adaptive methodology empowers monitors to be more than just box-checkers,” said Dr. Rosenberg. “Each team member has the training and tools to improve site performance. When the whole team is thinking critically about the overall health of the study, you get better quality data and faster execution at every stage, from start-up and enrollment through database lock and submission."

"Centralized Monitoring: When Does It Make Sense?" will explore monitoring solutions that provide economies of scale, allocate resources efficiently, optimize every aspect of operations, and alleviate sponsors’ concerns about budget and timelines. Such solutions include:

· Need-based monitoring visits: how to reliably and efficiently determine when to dispatch monitors to sites;
· Managing based on performance metrics: which metrics to look for, how to track and report trends, and what actions to take when opportunities to improve efficiency are indicated;
· Automated data capture and processing tools;
· Electronic data as source documents.

The session will be chaired by Ramita Tandon, MPH, MSc, senior director, project management, per-approval services (PACE) at PAREXEL International. The session is part of the Clinical Research and Development/Clinical Supplies (CR/CS) track, and takes place June 14 from 3:30 – 5:00 p.m. EDT in Room 145B.

About Health Decisions
Health Decisions (HealthDec.com) is a global clinical research organization (CRO) committed to helping drug and device companies achieve greater success. Our sponsors rely on us to help them prove the value of their pipelines both faster and with the smartest possible allocation of funds. Through Agile Clinical Development—a strategic combination of adaptive design and adaptive operations—Health Decisions optimizes every facet of clinical research from design protocol to the most detailed day-to-day management, so sponsors can make the most of competitive market opportunities.

Health Decisions is headquartered in Durham, NC, with over twenty years of experience helping sponsors achieve success in Phase I-IV trials across all major therapy areas. For more information, please visit the company's website at the link accompanying this press release.

About the DIA Annual Meeting
Hosted by the Drug Information Association, the DIA 46th Annual Meeting takes place June 13 – 17, 2010 at the Walter E. Washington Convention Center, Washington, DC. The DIA Annual Meeting is the biopharmaceutical industry's largest, longest running, best-value, global, multidisciplinary event. To learn more, visit DIA online.

About the Drug Information Association (DIA)
DIA is a neutral, global, professional, member-driven association of nearly 18,000 industry, academia, and regulatory professionals involved in the discovery, development, and life cycle management of pharmaceuticals, medical devices, and related products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well-being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Health Decisions

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Health Decisions CEO Explores Adaptive Monitoring Techniques for Late-Stage Clinical Studies at DIA

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Katie Hendrick - HealthDec.com 
919-967-1111 x116 khendrick[.]HealthDec.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Health Decisions securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Health Decisions / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Press Releases:

SCHOTT Pharma Unveils Innovative Nest Design for Ready-to-use Cartridges
Ipsen and Biomunex Announce Exclusive Global Licensing Agreement for First-in-class MAIT Cell Engager in Immuno-oncology
Bushu Pharma Applauded by Frost & Sullivan for Offering Customer Value in APAC CDMO Industry through Consistent Quality Assurance, On-time Delivery
Bylvay® (odevixibat) Data Shows Sustained Improvement in Severe Itch and Serum Bile Acid Levels in Patients with PFIC and ALGS
Genome BC, STEMCELL Technologies and UBC Partner to Accelerate the Ability to Develop Stem Cells
PathogenDx Applauded by Frost & Sullivan for Enabling Early and Precise UTI Diagnosis with its Microarray Detection Platform
BASF Partners with Acies Bio to Drive Sustainable Production of Personal and Home Care Ingredients
Ipsen’s Kayfanda® (odevixibat) Approved in European Union for Cholestatic Pruritus in Alagille Syndrome, A Rare Liver Disease
STEMCELL Technologies and Axion BioSystems Partner to Streamline Culture and Analysis of Excitable Cells
Frost & Sullivan Awards Avance Clinical for Global Biotech CRO Excellence, Highlighting Agility, Responsiveness, Customer Value

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com







 
  ©2005-2024 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today